4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-017084
Co-Chief Executive Officer acquired 334,520 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2022-05-05 | Option exercise | +334,520 | $0.37 | $123,772 | 2,898,585 | D |
| Derivatives | |||||||
| Klee Justin B. Co-Chief Executive Officer | 2022-05-05 | Option exercise · Stock Option (right to buy) | −334,520 | 0 | D | ||
Loading xslF345X03/doc4.xml…